Insilico Medicine Company

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Connections

Technology: Artificial Intelligence, Biotechnology, Genetics, Health Care, Pharmaceutical
Industry: AI, End-to-end Drug Development
Headquarters: Hong Kong, Hong Kong Island, Hong Kong
Zip: 101-250
Founded Date: 2014-01-01
Employees Number: 101-250
Funding Status: Late Stage Venture
Acquisitions Number: 31
Investors Number: 32
Total Funding: 401300000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-08-10
Last Funding Type: Series D

Visit Website
ai@insilico.com
http://twitter.com/InsilicoMeds
Register and Claim Ownership